# Antibiotic-Driven Evolutionary Engineering in Salmonella Heidelberg Reveals Genomic Signatures of Attenuation

**Authors:** Ruy D. Chacón, Manuel Ramírez, Claudete S. Astolfi-Ferreira, Antonio J. Piantino Ferreira

PMC · DOI: 10.3390/genes17020235 · Genes · 2026-02-12

## TL;DR

This study shows how exposing Salmonella Heidelberg to antibiotics leads to genetic changes that may reduce its virulence, offering insights into vaccine development.

## Contribution

The study identifies specific genomic mutations and functional networks linked to attenuation in Salmonella Heidelberg through antibiotic-driven evolutionary engineering.

## Key findings

- Mutant strains showed resistance to streptomycin and rifampicin with distinct genetic mutations.
- Genes like rpoS, ascD, and rpoB were linked to antibiotic resistance and virulence attenuation.
- Network analysis revealed functional connections in regulatory and metabolic pathways affected by mutations.

## Abstract

Background/Objectives: Salmonella Heidelberg (SH) is a globally distributed pathogen associated with gastrointestinal disease in humans and animals and frequently affects poultry. Among the classic strategies used in vaccine development, evolutionary engineering enables the generation of attenuated bacterial strains through exposure to selective pressures such as antibiotics. In this study, spontaneous antibiotic-resistant mutant strains of SH were generated by exposure to high concentrations of streptomycin and rifampicin, after which their phenotypic and genotypic characteristics were evaluated. Methods: The wild-type strain SA628 wt was subjected to continuous and discontinuous selection under antibiotic pressure. Phenotypic characterization included biochemical profiling and antibiotic susceptibility testing. Whole-genome sequencing was performed to identify genetic changes affecting virulence- and resistance-associated genes, plasmid content, and point mutations using variant calling approaches. The potential functional relationships of the mutated genes were further analyzed through genetic network analysis. Results: The mutant strains SA628 mut1 and SA628 mut3 were obtained through discontinuous selection, whereas strain SA628 mut2 was generated under continuous selection. Phenotypically, all the mutant strains exhibited resistance to streptomycin, whereas SA628 mut2 and SA628 mut3 also exhibited resistance to rifampicin. Genomic analyses revealed mutations in rpoS, ascD, ynfE, rpoB, and cyaA associated with discontinuous selection and in iscU, ybiO, rpoB, and rsmG associated with continuous selection. Network analysis indicated that these genes are functionally connected within regulatory and metabolic interaction networks, including global transcriptional regulation, anaerobic metabolism, cAMP-mediated signaling, translation, and iron–sulfur cluster biogenesis. Conclusions: Collectively, these findings suggest that antibiotic-driven selection promotes coordinated genetic changes affecting stress responses and metabolism, which may contribute to reduced virulence. This work provides insights into bacterial adaptation under antibiotic stress and supports the potential use of evolutionary engineering for the development of attenuated strains.

## Linked entities

- **Genes:** rpoS (RNA polymerase sigma factor RpoS) [NCBI Gene 880421], ynfE (hypothetical protein) [NCBI Gene 936469], rpoB (RNA polymerase beta subunit) [NCBI Gene 800292], cyaA (adenylate cyclase) [NCBI Gene 877744], ISCU (iron-sulfur cluster assembly enzyme) [NCBI Gene 23479], ybiO (mechanosensitive channel protein) [NCBI Gene 917623], rsmG (16S rRNA methyltransferase) [NCBI Gene 915344]
- **Chemicals:** streptomycin (PubChem CID 5297), rifampicin (PubChem CID 135398735)

## Full-text entities

- **Genes:** CDS1 (CDP-diacylglycerol synthase 1) [NCBI Gene 1040] {aka CDS 1}, HSCB (HscB mitochondrial iron-sulfur cluster cochaperone) [NCBI Gene 150274] {aka DNAJC20, HSC20, JAC1, SIDBA5}, CUL9 (cullin 9) [NCBI Gene 23113] {aka H7AP1, PARC}, SQLE (squalene epoxidase) [NCBI Gene 6713], CHGA (chromogranin A) [NCBI Gene 1113] {aka CGA, PHE5, PHES}, rpoB [NCBI Gene 888164], TOP2A (DNA topoisomerase II alpha) [NCBI Gene 7153] {aka TOP2, TOP2alpha, TOPIIA, TP2A}, SPI1 (Spi-1 proto-oncogene) [NCBI Gene 6688] {aka AGM10, OF, PU.1, SFPI1, SPI-1, SPI-A}
- **Diseases:** SH (MESH:D012480), gastroenteritis (MESH:D005759), injury to (MESH:D014947), infection (MESH:D007239), gastrointestinal disease (MESH:D005767)
- **Chemicals:** Fe-S (MESH:D007501), nalidixic acid (MESH:D009268), CDP (MESH:D003565), erythromycin (MESH:D004917), amoxicillin (MESH:D000658), aminoglycosides (MESH:D000617), sugar (MESH:D000073893), oxygen (MESH:D010100), O-antigens (MESH:D019081), doxycycline (MESH:D004318), enrofloxacin (MESH:D000077422), NaCl (MESH:D012965), T/S (MESH:D014316), agar (MESH:D000362), ciprofloxacin (MESH:D002939), streptomycin (MESH:D013307), ceftiofur (MESH:C053503), cefpodoxime (MESH:C053268), lactose (MESH:D007785), ansamycins (MESH:D047029), novobiocin (MESH:D009675), agarose (MESH:D012685), trimethoprim/sulfamethoxazole (MESH:D015662), citrate (MESH:D019343), indole (MESH:C030374), neomycin (MESH:D009355), CPP (MESH:C014896), DOX (MESH:D004317), fosfomycin (MESH:D005578), tetracycline (MESH:D013752), AMX (-), H2S (MESH:D006862), cefotaxime (MESH:D002439), quinolone (MESH:D015363), RIF (MESH:D012293), CET (MESH:D002512)
- **Species:** Salmonella enterica (species) [taxon 28901], Salmonella enterica subsp. enterica serovar Typhimurium (no rank) [taxon 90371], Symbiobacterium thermophilum (species) [taxon 2734], Escherichia coli (E. coli, species) [taxon 562], Salmonella (genus) [taxon 590], Salmonella enterica subsp. enterica serovar Enteritidis (no rank) [taxon 149539], Mus musculus (house mouse, species) [taxon 10090], Francisella tularensis (species) [taxon 263], Gallus gallus (bantam, species) [taxon 9031], Yersinia (genus) [taxon 444888], Salmonella enterica subsp. enterica (subspecies) [taxon 59201], Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Mycobacterium tuberculosis (species) [taxon 1773]
- **Mutations:** c.249_258dupACTGCGTGGA, c.437C>G, S83F, p.Ser146Trp, T57S, p.Arg429His, 437C>A, Gln513Leu, C for 18-24, p.Gln306Leu, T/S, 463G>T, 547G>T, c.1286G>A, c.1538A>T, c.1577A>T, His526Leu, c.917A>T, p.Asp87fs, c.318C>A
- **Cell lines:** SA628 — Homo sapiens (Human), Hypertrophic cardiomyopathy, Induced pluripotent stem cell (CVCL_LF06)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940389/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940389/full.md

## References

97 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940389/full.md

---
Source: https://tomesphere.com/paper/PMC12940389